IFN-α/βRβ siRNA (h) from Santa Cruz Biotechnology, Inc.

Product Specs
ItemIFN-α/βRβ siRNA (h)
CompanySanta Cruz Biotechnology, Inc.
Price $293.00Supplier Page View Company Product Page
Catalog Numbersc-40091
Quantity10 µM
Gene Nameinterferon (alpha, beta and omega) receptor 2
Specieshuman
TypesiRNA/dsRNA
NCBI Full Gene Nameinterferon alpha and beta receptor subunit 2
NCBI Gene AliasesIFN-R, IFN-R-2, IFN-alpha-REC, IFNABR, IFNARB, IMD45

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Type-I-interferon signaling drives microglial dysfunction and senescence in human iPSC models of Down syndrome and Alzheimer's diseaseCell stem cellJuly 7, 2022Jin M, Xu R, Wang L, Alam MM, Ma Z, Zhu S, Martini AC, Jadali A, Bernabucci M, Xie P, et al.

(2) Nrf2 negatively regulates STING indicating a link between antiviral sensing and metabolic reprogrammingNature communicationsAugust 29, 2018Olagnier D, Brandtoft AM, Gunderstofte C, Villadsen NL, Krapp C, Thielke AL, Laustsen A, Peri S, Hansen AL, Bonefeld L, et al.

(3) RIG-I-Mediated STING Upregulation Restricts Herpes Simplex Virus 1 InfectionJournal of virologyOctober 15, 2016Liu Y, Goulet ML, Sze A, Hadj SB, Belgnaoui SM, Lababidi RR, Zheng C, Fritz JH, Olagnier D, Lin R.(IFN-␣/␤R) ␣ chain (catalog number sc-35637; Santa Cruz Biotechnology) and ␤ chain (catalog number sc-40091; Santa Cruz Biotechnology), STAT1 (catalog number sc-44123; Santa Cruz Biotechnology), STING (catalog

(4) Inhibition of dengue and chikungunya virus infections by RIG-I-mediated type I interferon-independent stimulation of the innate antiviral responseJournal of virologyApril 1, 2014Olagnier D, Scholte FE, Chiang C, Albulescu IC, Nichols C, He Z, Lin R, Snijder EJ, van Hemert MJ, Hiscott J.

(5) Correction: Systems Analysis of a RIG-I Agonist Inducing Broad Spectrum Inhibition of Virus InfectivityPLoS PathogensAugust 8, 2013Marie-Line Goulet et al.A549 cells were transfected with 50 nM (30 pmol) of human RIG-I (sc-61480), IFN-a/bR a (sc-35637) and b (sc-40091) chain, or control siRNA (sc-37007) (Santa Cruz Biotechnologies, Dallas, USA) using Lipofectamine RNAi

(6) Systems analysis of a RIG-I agonist inducing broad spectrum inhibition of virus infectivityPLoS pathogensJanuary 1, 2013Goulet ML, Olagnier D, Xu Z, Paz S, Belgnaoui SM, Lafferty EI, Janelle V, Arguello M, Paquet M, Ghneim K, et al.A549 cells were transfected with 50 nM (30 pmol) of human RIG-I (sc-61480), IFN-α/βR α (sc-35637) and β (sc-40091) chain, or control siRNA (sc-37007) (Santa Cruz Biotechnologies, Dallas, USA) using Lipofectamine RNAi

Be the First to Write a Review!